Chord Energy (NASDAQ:CHRD) Bolsa

Chord Energy

Chord Energy Corp is an independent exploration and production company. The company acquires, exploits, develops, and explores crude oil, natural gas, and natural gas liquids in the Williston Basin.

Long Ideas

News

Markets

Media

Trading Ideas

CHRD

LRCX

REKR

SOUN

Jim Cramer llama a SoundHound AI una acción meme, su opinión sobre Lam Research y su favorita de energía, Enterprise Products Partners.

SoundHound AI y las recomendaciones de Cramer: ¿Inversión inteligente o especulación?

Chord Energy Corp

OCUL

Ocular Therapeutix To Highlight Advancements In Sustained-Release Axitinib Hydrogel For Retinal Disease At CTS 2025

VivoPower International PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVPR#NASDAQ">VVPR</a>) ("VivoPower") announced today that it has engaged advisors to fast-track execution in relation to its previously announced plan to directly spin off Caret LLC ("Caret Digital") through an IPO on NASDAQ.
&nbsp;
Caret Digital's strategy will be focused on digital asset mining, with an emphasis on mining DOGE as previously announced. With the first six-month phase of mining DOGE nearing successful completion, VivoPower is confident of the scalability of the business. Leveraging DOGE mining economics, Caret Digital will convert mined DOGE into either XRP or BTC, securing both at an effective discount (based on current DOGE mining economics), which will then allow it to execute on strategies to optimise yield and returns.
The implied market capitalisation for the spin-off is US$308 million (subject to change based on market conditions and other factors). Additionally, Caret Digital intends to raise up to US$50 million from strategic investors as part of the transaction to support growth plans and it has been engaged in negotiations with counterparties in the Middle East and Asia. Since the election of US President Donald Trump and the recent investment of the Trump brothers in digital asset mining, there has been a significant increase in interest in digital asset mining activities outside of the United States, including in countries where such activity has previously been prohibited. In addition, renewable power sources at sub 3c/watt have been identified.

IPOs

VVPR

VivoPower Fast-Tracks $308M Spin-Off of Crypto Unit Caret Digital Amid Global Mining Boom

<ul>
<li>Real-world data highlight significant challenges with LTP adherence, and ongoing reliance on on-demand medications.</li>
<li>In KONFIDENT-S, oral sebetralstat delivered rapid, consistent relief for breakthrough attacks, regardless of long-term prophylaxis mechanism of action</li>
</ul>

Biotech

Health Care

General

KALV

KalVista Pharmaceuticals Announced The Presentation Of New Data At The European Academy Of Allergy And Clinical Immunology Congress 2025

American Express Unveils Largest-Ever Platinum Card Refresh With Expanded Travel, Dining, And Business Perks

Approval advances transaction that will create America's leading reliable and clean energy provider, with coast-to-coast presence
Constellation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) today announced it has received regulatory approval from the New York State Public Service Commission (PSC) for its <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.constellationenergy.com%2Fnewsroom%2F2025%2Fconstellation-to-acquire-calpine-creates-americas-leading-producer-of-clean-and-reliable-energy-to-meet-growing-demand-for-customers-and-communities.html&amp;esheet=54273602&amp;newsitemid=20250612288071&amp;lan=en-US&amp;anchor=previously+announced&amp;index=1&amp;md5=fa14a2fe8096a883d1ad46429eaf16b5">previously announced</a> acquisition of Calpine Corporation.
The approval represents the most recent key step forward in Constellation's plans to combine the nation's largest zero-emissions nuclear fleet with Calpine's premier portfolio of low-emission natural gas and geothermal assets. The deal will establish a coast-to-coast platform capable of supporting growing demand for around-the-clock, sustainable power.

Constellation Receives Regulatory Approval From New York State PSC For Its Previously Announced Acquisition Of Calpine Corp.

<ul>
<li>iBio nominates IBIO-610 as development candidate for its first-in-class Activin E antibody</li>
<li>New study aims to evaluate the half-life of IBIO-610 in obese, elderly non-human primates (NHP) and assess early signs of efficacy on fat reduction and body composition</li>
<li>Mouse study shows IBIO-610 alone drives an overall body weight loss of 8.9%&#x2A;, and prevents weight regain following GLP-1 treatment in obese mice, results of which will be presented at ADA on Monday June 23rd</li>
</ul>

IBIO

iBio Initiates Non-human Primate Study For Its Activin E Engineered Antibody Candidate, Now Named IBIO-610. This Preclinical Study Will Evaluate The Pharmacokinetics And Early Signs Of Efficacy Of IBIO-610 In Obese And Elderly NHPs, Including Its Impact On Fat And Body Composition

NXTC

NextCure Announced Strategic Partnership With Simcere Zaiming To Develop SIM0505, a CDH6-Targeting Antibody-Drug Conjugate for Solid Tumors

<ul>
<li>New Toyota&nbsp;Prius Plug-in&nbsp;Hybrid Nightshade Edition Available in 2026</li>
<li>Available in&nbsp;Karashi, Wind Chill Pearl, and Midnight Black Metallic</li>
<li>Up to 44-Miles of Manufacturer-Estimated All Electric Driving Range Rating&nbsp;</li>
<li>Up to a Manufacturer-Estimated 52 Combined MPG Rating in Hybrid Mode&nbsp;</li>
<li>Standard Toyota Audio Multimedia and Toyota Safety Sense 3.0</li>
</ul>
PLANO, Texas, June 16, 2025 /PRNewswire/ -- For 2026, Toyota is introducing the Prius Plug-in&nbsp;Hybrid Nightshade Edition – a bold new chapter in the Prius lineup that fuses sleek sophistication with an unmistakable edge. Built off the XSE grade, the Nightshade Edition elevates the iconic design with an array of captivating black accents that enhance the already stunning profile. From the sleek black badging and door sills to the stylish door handles and bumper trim, every detail has been meticulously crafted to create a cohesive and aggressive look.
The 2026 Prius Plug-in Hybrid is expected to arrive at Toyota dealerships this summer. The Manufacturer's Suggested Retail Price, excluding Dealer Processing and Handling, will start at $33,775 for the SE grade.&nbsp;
 &nbsp;

Toyota Introduces Prius Plug-In Hybrid Nightshade Edition For 2026

If approved by the FDA, Anaphylm would be the first and only orally delivered epinephrine option for the treatment of severe allergic reactions in the United States.

AQST

The FDA Has Accepts Aquestive Therapeutics' New Drug Application For Anaphylm For Type 1 Allergic Reactions, Including Anaphylaxis, With PDUFA Target Action Date Of January 31, 2026

Taoping Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>, the ", Company", ))), a provider of innovative smart cloud platform services and solutions, today announced that on June 13, 2025, it received notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming the Company has cured its bid price deficiency, and that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2). Accordingly, this matter is now closed and the Company's ordinary shares will continue to trade uninterrupted on Nasdaq under the ticker "TAOP".

TAOP

Taoping Regains Nasdaq Compliance, Stock To Trade Uninterrupted

On Friday, June 13, U.S. markets ended sharply lower as escalating Iran-Israel tensions rattled global markets. Oil prices jumped on fears of supply disruption, boosting energy and defense stocks, while airlines tumbled on rising fuel concerns.
Most sectors in the S&amp;P 500 declined, led by financials and tech. Despite positive consumer sentiment and stable inflation data, geopolitical risks weighed heavily on investor confidence and market performance.
According to economic data, the University of Michigan&#8217;s consumer sentiment index rose to 60.5 in June, up from 52.2 in the prior two months and above expectations of 53.5.
While most S&amp;P 500 sectors, including financials, tech, and materials, posted losses Friday, energy stocks closed higher against the trend. The Dow closed lower by 1.79% at 42,197.79, the S&amp;P 500 declined 1.13% to 5,976.97, and the Nasdaq slipped 1.30% to 19,406.83.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/macro-economic-events/25/06/45943707/us-economy-to-face-pretty-limited-impact-from-israel-iran-airstrikes-with-only-a-tiny-bit-recession-risk-say-economists" rel="noreferrer noopener">US Economy To Face &#8216;Pretty Limited&#8217; Impact From Israel-Iran Airstrikes, With Only A &#8216;Tiny Bit&#8217; Recession Risk, Say Economists</a>
<h2 class="wp-block-heading">Asia Markets Today</h2>
On Monday, Japan&#8217;s Nikkei 225 closed 1.29% higher at 38,324.00, led by gains in the Real Estate, Banking, and Textile sectors.
Australia&#8217;s S&amp;P/ASX 200 was up 0.01% at 8,548.40, led by gains in the Energy, IT and Telecoms Services sectors.
India&#8217;s Nifty 50 was up 0.89% at 24,937.40, and the Nifty 500 gained 0.79% to 23,086.95.
China&#8217;s Shanghai Composite was up 0.35% at 3,388.73, and Shanghai Shenzhen CSI 300 rose 0.25% to 3,873.80.
Hong Kong&#8217;s Hang Seng closed the session 0.70% higher at 24,060.9
<h2 class="wp-block-heading">Eurozone at 05:45 AM ET</h2>
The European STOXX 50 index was up 0.42%.
Germany&#8217;s DAX index gained 0.32%.
France&#8217;s CAC 40 rose 0.71%.
U.K.&#8217;s FTSE 100 index traded higher by 0.38%.
<h2 class="wp-block-heading">Commodities at 05:45 AM ET</h2>
Crude Oil WTI was trading lower by 0.60% at $70.86/bbl, and Brent was down 0.73% at $73.74/bbl.
Oil prices dipped Monday after a sharp surge on Friday, as Israeli-Iranian strikes over the weekend left oil facilities intact. Brent and WTI futures gave back earlier gains despite briefly rising over $4 in Asian trading.
Natural gas rose 2.90% to $3.685.
Gold traded lower by 0.61% to $3,431.70, Silver rose 0.10% to $36.393, and Copper fell 0.28% to $4.8008.
<h2 class="wp-block-heading">U.S. Futures</h2>
At 05:45 AM ET, the Dow Jones futures rose 0.36%, the S&amp;P 500 gained 0.41%, and Nasdaq 100 was up 0.49%.
<h2 class="wp-block-heading">Forex</h2>
At 05:45 AM ET, the U.S. Dollar Index declined 0.24% to 97.98, USD/JPY was up 0.01% to 144.12, and USD/AUD declined 0.42% to 1.5348.
The dollar held steady Monday amid Israel-Iran tensions and ahead of key central bank meetings, while risk currencies edged higher and oil prices eased from last week&#8217;s surge.
Photo via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Rise, Dollar Slips Ahead Of Central Bank Decisions - Global Markets Today While US Slept

Highlights:
<ul>
<li>Over $11 Million Raised:&nbsp;Proceeds were generated through the exercise of existing warrants. Chardan Capital Markets was the exclusive financial advisor in connection with public warrant exercises.</li>
<li>Update on NASDAQ Compliance:&nbsp;Klotho believes it now exceeds the stockholders' equity thresholds required to remain in compliance with NASDAQ listing requirements.</li>
<li>Zero Debt:&nbsp;Klotho has fully extinguished all outstanding debt, resulting in a debt-free balance sheet.</li>
</ul>
NEW YORK, June 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biogenetics company, today announced that over the course of the last ten days, it raised over $11 million in funding through the exercise of existing warrants by investors. The Company believes that it now surpasses Nasdaq's stockholders' equity requirement requirements outlined in its Nasdaq compliance plan.

KLTO

Klotho Neurosciences Raises Over $11M In Funding Through Exercise Of Existing Warrants By Investors

<ul>
<li>Proposed acquisition expected to accelerate mid- to long-term revenue and cash flow growth and further diversify revenue base.</li>
<li>Strengthens Supernus' leading presence in neuropsychiatric conditions with an innovative commercial product, ZURZUVAE&#xAE; (zuranolone), and a novel CNS discovery platform.</li>
<li>Expected to be significantly accretive in 2026 with potential cost synergies of up to $200 million on an annual basis.</li>
<li>Upfront cash payment of $8.50 per share, plus one non-tradable contingent value right (CVR) payable upon achieving certain specific milestones collectively worth up to $3.50 per share in cash, for an aggregate of up to approximately $795 million or $12.00 per share.</li>
</ul>

SAGE

SUPN

Supernus Pharmaceuticals Agrees To Buy Sage Therapeutics For $8.50/Share Plus One Contingent Value Right Worth Up To $3.50 Per Share In Cash, For Total Consideration Of $12/Share

Coda Octopus Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CODA#NASDAQ">CODA</a>) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.03 by 166.67 percent. This is a 38.46 percent decrease over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $7.02 million which beat the analyst consensus estimate of $4.46 million by 57.16 percent. This is a 31.82 percent increase over sales of $5.32 million the same period last year.

Earnings

Earnings Beats

CODA

Coda Octopus Group Q2 EPS $0.08 Beats $0.03 Estimate, Sales $7.02M Beat $4.46M Estimate

AIOT

PowerFleet Q4 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $103.64M Beat $103.59M Estimate

Powerfleet Expands Deployment Of Advanced AI Video Safety Solution With EverDriven Technologies

95.5% of patients with relapsed or refractory marginal zone lymphoma (MZL) treated with lisocabtagene maraleucel (liso-cel) achieved a response, with 62.1% achieving complete response and 88.6% maintaining a response at 24 months
New data show liso-cel demonstrated high rates of durable responses and a consistent safety profile in a fifth cancer type, the most of any CD19-directed CAR T cell therapy
Additional liso-cel data at ICML 2025 further reinforce BMS' commitment to unlocking the full potential of this therapy for patients
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.bms.com%2F&amp;esheet=54275367&amp;newsitemid=20250613870408&amp;lan=en-US&amp;anchor=Bristol+Myers+Squibb&amp;index=1&amp;md5=d665851409cd5753f968a6745c7e20f9">Bristol Myers Squibb</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) today announced the first disclosure of the primary analysis results of the marginal zone lymphoma (MZL) cohort of TRANSCEND FL, an open-label, global, multicenter, Phase 2, single-arm study evaluating Breyanzi (lisocabtagene maraleucel; liso-cel) in patients with relapsed or refractory disease. The new data will be presented at the 2025 International Conference on Malignant Lymphoma (ICML) in an oral presentation on June 19, building on <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnews.bms.com%2Fnews%2Fcorporate-financial%2F2025%2FBristol-Myers-Squibb-Announces-Positive-Topline-Results-for-Breyanzi-lisocabtagene-maraleucel-in-Adult-Patients-with-Relapsed-or-Refractory-Marginal-Zone-Lymphoma%2Fdefault.aspx&amp;esheet=54275367&amp;newsitemid=20250613870408&amp;lan=en-US&amp;anchor=positive+topline+results&amp;index=2&amp;md5=ab804680ec7fa20a8268604cd3793fbb">positive topline results</a> announced in February.

Bristol Myers Squibb Announces First Disclosure Of Primary Analysis Results Of MZL Cohort Of TRANSCEND FL, Phase 2, Single-Arm Study Evaluating Breyanzi In Patients With Relapsed Or Refractory Disease

The GEO Group, Inc. (NYSE:<a href="https://www.benzinga.com/stock/GEO#NYSE">GEO</a>) ("GEO" or the "Company") announced today that its wholly-owned subsidiary, GEO Transport, Inc. has entered into a new five-year contract, inclusive of option periods, with the U.S. Marshals Service for the provision of secure transportation and contract detention officer services across three service regions covering 26 federal judicial districts and spanning 14 states.
The new contract is expected to generate up to approximately $147 million over the five-year period, or up to approximately $29 million in annualized revenues per full-year of operations, with margins consistent with GEO's Managed-Only services contracts which average approximately 15 percent.

Contracts

GEO Transport Secures 5-Yr Deal Valued At ~$147M With U.S. Marshals Service For Provision Of Secure Transportation And Contract Detention Officer Services

Needham analyst Laura Martin initiates coverage on MNTN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MNTN#NYSE">MNTN</a>) with a Buy rating and announces Price Target of $25.

Price Target

Initiation

Analyst Ratings

MNTN

Needham Initiates Coverage On MNTN with Buy Rating, Announces Price Target of $25

Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending

Press Releases

Chord Energy Schedules Third Quarter 2024 Earnings Release and Conference Call

Chord Energy Reports Strong Third Quarter 2024 Financial and Operating Results, $146MM of Share Repurchases and Issues 2025 - 2027 Outlook

Chord Energy Schedules Fourth Quarter and Year End 2024 Earnings Release and Conference Call

Chord Energy Reports Strong Fourth Quarter and Full-Year 2024 Financial and Operating Results, Issues 2025 Outlook and Increases Base Dividend

Offerings

Chord Energy Corporation Announces $750 Million Offering of Senior Notes

CHORD ENERGY CORPORATION ANNOUNCES A CASH TENDER OFFER FOR ANY AND ALL OF ITS OUTSTANDING 6.375% SENIOR NOTES DUE 2026

Chord Energy Corporation Announces Pricing of $750 Million Offering of Senior Notes

Chord Energy Corporation Announces Pricing of Cash Tender Offer for Any and All of its Outstanding 6.375% Senior Notes Due 2026

Chord Energy Schedules First Quarter 2025 Earnings Release and Conference Call

Chord Energy Reports First Quarter 2025 Financial and Operating Results, Declares Base Dividend and Issues Updated Outlook

Antero Resources Corporation Common Stock

Antero Resources

CNX Resources

ConocoPhillips

California Resources Corporation Common Stock

California Resources

Comstock Resources

Coterra Energy

Devon Energy

EOG Resources

Expand Energy

Diamondback Energy

Gulfport Energy Corporation Common Shares

Gulfport Energy

Hess

Magnolia Oil & Gas Corporation Class A Common Stock

Magnolia Oil & Gas

Matador Resources

Murphy Oil

Ovintiv

Permian Resources Corporation Class A Common Stock

Permian Resources

Range Resources

Texas Pacific Land Corporation Common Stock

Texas Pacific Land

Venture Global, Inc. Class A common stock

Venture Global

Vista Energy S.A.B. de C.V. American Depositary Shares, each representing one series A share, with no par value

Vista Energy

Viper Energy, Inc. - Class A Common Stock

Viper Energy

Woodside Energy Group Limited American Depositary Shares, each representing one Ordinary Share

Comments

Chord Energy

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL